Management of Cardiac Implantable Electronic Devices in Patients With Severe Symptomatic Tricuspid Regurgitation—Proposed Algorithm and Selected Case Examples
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.31444 ↗Kurz gefasst
Fallbericht in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Mina M Kerolos und 4 weiteren Autor:innen. Beteiligte Einrichtung: Endeavor Health Cardiovascular Institute, Glenview, Illinois, USA. Hauptthemen laut MEDLINE: Algorithms, Cardiac Catheterization, Decision Support Techniques, Defibrillators, Implantable. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Severe tricuspid regurgitation (TR) is associated with significant morbidity and mortality. Management of severe TR includes treatment of the underlying cause(s), medical therapy and less commonly surgical tricuspid valve repair. Newer transcatheter tricuspid valve repair devices show promise for those patients who remain symptomatic with severe TR despite such efforts. The presence of a Cardiac Implantable Electronic Device (CIED) with leads across the tricuspid valve poses a significant challenge from both diagnostic and therapeutic standpoints. In this paper, we propose an algorithm to manage patients with CIED leads across the tricuspid valve and symptomatic TR. We include case studies to illustrate implementation of the algorithm in clinical care. Key takeaway messages: (1) CIED leads across the tricuspid valve (TV) in the setting of TR are often innocent but may be causal and/or interfere with valve imaging. (2) CIED lead extraction often does not reduce TR and is reserved for select patients. (3)Transcatheter TV interventions can be performed in the presence of CIED leads. (4) An algorithm‐driven interventional cardiology, electrophysiology and advanced imaging team approach is needed to best manage TR in the setting of CIED leads.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Endeavor Health Cardiovascular Institute, Glenview, Illinois, USA.
ORCID-Profile: Mina M Kerolos
Zitieren
APA
Kerolos, M. M., Lee, K., Najman, D. M., Metzl, M. D., & Ricciardi, M. J. (2025). Management of Cardiac Implantable Electronic Devices in Patients With Severe Symptomatic Tricuspid Regurgitation—Proposed Algorithm and Selected Case Examples. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31444
Vancouver
Kerolos MM, Lee K, Najman DM, Metzl MD, Ricciardi MJ. Management of Cardiac Implantable Electronic Devices in Patients With Severe Symptomatic Tricuspid Regurgitation—Proposed Algorithm and Selected Case Examples. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31444
BibTeX
@article{Kerolos2025,
author = {Kerolos, Mina M and Lee, Kevin and Najman, David M and Metzl, Mark D and Ricciardi, Mark J},
title = {Management of Cardiac Implantable Electronic Devices in Patients With Severe Symptomatic Tricuspid Regurgitation—Proposed Algorithm and Selected Case Examples},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.31444}
}
EUVIMED